Increasing or rescuing the expression of NDRG2 in WT and Ndrg2−/− mice significantly reduces the infarct volume, neurological outcome, and interstitial glutamate levels, suggesting a potentially therapeutic target for brain ischemia. Here, NDRG2 is linked to brain ischemia.